TSX: VPH | OTCQB: VPHIF | FSE: VP2
Valeo Pharma (TSX:VPH) is a Canadian pharmaceutical company focused on four therapeutic areas: Respiratory, Neurology, Oncology and Specialty Products. Within these areas Valeo now has 8 marketed brands and 4 additional products contributing to significant growth for the coming year.
Investor Relations Contact
Director Communications & Investor Relations
16667, Hymus Boul.
1 (416) 361-9080
Research Capital Corporation
1 (416) 860-8675